SCHEMBL25907901

SCHEMBL25907901

C#CCOc1ccc(C2(c3ccc(OCC#C)cc3)C(=O)N(CCCCN3C(=O)C(c4ccc(OCC#C)cc4)(c4ccc(OCC#C)cc4)c4ccccc43)c3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
GSTP1 P09211 1/20 0.41
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SCN9A Q15858 7/20 0.38
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PTGS2 P35354 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25907907 0.90 CA12 (0.40) CNR1GPR55GSTP1LMNASMN1; SMN2
SCHEMBL25502472 0.86 CNR1 (0.44) CNR1GPR55GSTP1LMNASCN9A
SCHEMBL25118996 0.86 CNR1 (0.38) CNR1GPR55GSTP1LMNASMN1; SMN2
SCHEMBL25119327 0.85 CNR1 (0.41) CNR1GPR55LMNASMN1; SMN2SCN9A
SCHEMBL25907915 0.84 CNR1 (0.40) CNR1GPR55LMNASMN1; SMN2SCN9A
SCHEMBL25908953 0.81 CNR1 (0.38) CNR1GPR55LMNASMN1; SMN2SCN9A
SCHEMBL25119328 0.81 CNR1 (0.38) CNR1GPR55LMNASMN1; SMN2SCN9A
SCHEMBL25909136 0.81 CNR1 (0.38) CNR1GPR55LMNASMN1; SMN2SCN9A
SCHEMBL25907914 0.80 CNR1 (0.45) CNR1GPR55LMNASMN1; SMN2SCN9A
SCHEMBL25907964 0.80 CA12 (0.33) CNR1GPR55SCN9ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-03 US disclosed
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM OR10J3, PYM1, AP1M1 CNR1 2565/4885GPR55 4460/4885GSTP1 3708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.